Send feedback

GAA p.Arg702Pro

c.2105G>C · rs398123172 · VCV593593

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 6 submitters
AlphaMissense
likely pathogenic
0.9513 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.52e-05%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
glycogen storage disease II

ClinGen expert panel — Lysosomal Diseases VCEP

Uncertain Significance for glycogen storage disease II. Applied ACMG criteria (verbatim):

PM3_Supporting PM2_Supporting PP3 PM5

Curation rationale (ClinGen, verbatim)

The NM_000152.5:c.12105G>C variant in GAA is a missense variant predicted to cause substitution of arginine by proline at amino acid 702 (p.Arg702Pro). It has been reported in one individual in national mutation database for the country of Oman (PMID: 26594346). However, no clinical details were provided and thus points can not be applied for PP4. This individual was compound heterozygous for the variant and variant classified as pathogenic by the ClinGen LD VCEP (c.2560C>T, p.Arg854Ter; ClinVar Variation ID: Variation ID: 4034, SCV001371731.1), phase unknown (PMID: 26594346) (PM3_supporting). This variant is absent in gnomAD v2.1.1. (PM2_Supporting). The computational predictor REVEL gives a score of 0.989 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). Another missense variant [c.2105G>T, p.Arg702Leu] in the same codon has been classified as pathogenic for Pompe disease by the ClinGen Lysosomal Diseases VCEP (ClinVar Variation ID: Variation ID: 92472) (PM5). There is a ClinVar entry for this variant (Variation ID: 593593). Due to insufficient evidence, this variant is classified as a variant of unknown significance for Pompe disease based on the GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 2.0): (PM5, PM3_supporting, PM2_supporting, PP3). (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on March 5, 2024).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9513likely pathogenic · top 5% in GAA
REVEL0.989strongly pathogenic-leaning
SaProtLLR -14.88damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.8, phastCons 1
Regional constrainto/e 1.03unconstrained · MANE · 15 kb · p 0.22 · regional, not allelic
Overall
CADD32.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.52e-05% European (non-Finnish) · 1/1,173,916 alleles
Overall 6.91e-05% 1/1,448,060 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GAA
Protein
p.Arg702Pro
Coding
c.2105G>C
MANE Select
NM_000152
dbSNP
rs398123172
Type
single nucleotide variant
Location
chr17:80113282 (GRCh38)
Gene constraint
LOEUF 1.008 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 92.32 · 19 PDB
Residue 702
a UniProt-annotated variant site (in iopd; no enzymatic activity; shows enzyme localization primarily in the er-golgi compartment suggesting that mutation could affect the normal processing and stability of the enzyme); a UniProt-annotated variant site (in iopd); an α-helix
Full GAA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycogen storage disease II — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycogen storage disease due to acid maltase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gaa-p-arg702pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown